Efficacy of the novel Plasmodium falciparum blood-stage vaccine RH5.1/AS01B in a phase I/IIA clinical trial

Míreanna comhchosúla

• Safety and immunogenicity of the novel plasmodium falciparum blood-stage vaccine RH5.1/AS01B in a phase I/IIA clinical trial
  de réir: Minassian, AM, et al.
  Foilsithe / Cruthaithe: (2017)
• Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination
  de réir: Minassian, AM, et al.
  Foilsithe / Cruthaithe: (2021)
• Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured onthe AGE1.CR.pIX Avian Cell Line
  de réir: Folegatti, P, et al.
  Foilsithe / Cruthaithe: (2019)
• In silico T cell epitope prediction identifies high value RH5 epitopes that correlate with response in vaccinees
  de réir: Terry, F, et al.
  Foilsithe / Cruthaithe: (2018)
• Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
  de réir: Folegatti, PM, et al.
  Foilsithe / Cruthaithe: (2020)